Policy Reports, Briefs and Consults 

This report provides an in-dept analysis of global trends in the news media portrayal of gene drive technology and its applications for disease prevention, bio-conservation and in agriculture between 2015 and 2018 and outlines best practices for public communication, stakeholder consultation and public engagement .

October 28, 2018

Gene Drives: Strategies for Public Engagement and Communication

Release date: November 30, 2018. For access and pricing, contact:


Hundreds of clinics in India offer unproven stem cell therapies despite having remarkably stringent guidelines and regulations for fraudulent advertisements and clinical practice. We discuss the challenges with current regulations, how a recently proposed amendment may further legitimize unproven stem cell therapies, and discuss paths forward in a global context. 

Tiwari, Shashank S., and Pranav N. Desai. "Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward." Cell stem cell (2018).

October 18, 2018

In: Susanne Müller, Henning Rosenau (Hrsg.)

Stammzellen - iPS-Zellen - Genomeditierung. Stem Cells - iPS Cells - Genome Editing, Seite 109 - 124

Reihe: Schriften zum Bio-, Gesundheits- und Medizinrecht, Bd. 34

Kalina Kamenova, Why Ethical Qualms over Human Embryonic Stem Cells Are No Longer Relevant: An Analysis of the Evolving Public Discourse and Regulatory Context for Stem Cell Research in Canada.

DOI: 10.5771/9783845291901-109

July 30, 2018

© 2018 by Canadian Institute for Genomics and Society. Proudly created with Wix.com

  • Facebook Social Icon
  • Twitter Black Round